Combination therapy reduced dense VLDL cholesterol significantly more than did fenofibrate or simvastatin monotherapy, the investigators found. Simvastatin lowered intermediate density lipoprotein (IDL) cholesterol significantly more than did fenofibrate.

• 研究者发现，联合治疗相对于但用非诺贝特或辛伐他汀显著的降低极低密度脂蛋白胆固醇的密度。辛伐他汀比非诺贝特降低中等密度脂蛋白胆固醇的作用显著。